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ABSTRACT 
 
 
 
          Oxidant/antioxidant imbalance has been implicated in the pathogenesis of 
neurological disorders associated both with aging and hypertension. Therefore, we 
determined oxidative status and antioxidant capacity in a time-course manner in the 
cerebral cortex (CC), cerebellum (CB) and brain stem (BS) of spontaneously 
hypertensive rats (SHR) and Wistar-Kyoto rats (WKY).  
          Six animals from WKY and SHR strains were sacrificed at 8, 16, 24, 32, 40, 48, 
56 and 64 weeks of age after measuring their blood pressure and body weight. CC, 
CB and BS were dissected out, homogenized and used for the following estimations: 
thiobarbituric acid reactive substances (TBARS), protein carbonyl (PCO), superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione 
reductase (GR), glutathione S-transferase (GST), reduced glutathione (GSH), 
oxidized glutathione (GSSG), total antioxidant status (TAS) and membrane-bound 
enzymes activities (Na+,K+-ATPase, acetylcholinesterase - AChE).  
          SHR showed higher blood pressure and lower body weights at all time points 
studied. When compared to control, TBARS from week 24 and PCO from week 32 
onwards increased significantly in all brain regions of SHR. GSH content and 
GSH/GSSG ratio were lower in SHR from weeks 16 and 24 onwards respectively in 
all brain regions. TAS and activities of SOD and GST were significantly decreased in 
all brain regions from 24 weeks onwards in SHR. GPx activity showed significant 
decrease in CB and BS from week 24 and CC from week 56 onwards in SHR. CAT 
activity was significantly lower in CB from week 32 and CC from week 56 onwards 
in SHR. There was no difference in CAT activity in BS at all time points studied. GR 
activity showed significant decrease in CC, CB and BS from weeks 48, 16 and 24 
 xxxiv
onwards respectively in SHR. Na+,K+-ATPase showed significant decrease in its 
activity from week 32 onwards in all brain regions of SHR. AChE activity was 
significantly lower in CC, CB and BS from weeks 24, 32 and 48 onwards respectively 
in SHR. All three brain regions had similar SOD activity. BS of WKY and SHR had 
significantly higher TAS, activities of CAT and GPx, and lower TBARS and PCO 
levels in comparison to CC. Similar PCO levels and GPx activity were found in CB 
and BS, but significantly higher TAS and CAT activity, and lower TBARS levels 
were found in BS compared to CB. However, GSH contents, GSH/GSSG ratio and 
activities of GST and GR were significantly lower in BS compared to CC and CB. CC 
and CB had similar TBARS and PCO levels, GSH contents and TAS, but activities of 
GPx, CAT and GR were significantly lower in CC compared to CB. 
          It is suggested that the brain regions toward oxidative stress is in the order: 
CC>CB>BS. Along with progression of hypertension, there is increased oxidants 
level and decreased antioxidants capacity with alteration in membrane-bound 
enzymes activities in CC, CB and BS of SHR. Thus, oxidative stress may play a role 
in hypertension-associated neurological diseases. 
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ABSTRAK 
 
 
 
          Ketidakseimbangan oksidan/antioksidan dikatakan terlibat dalam patogenesis 
gangguan neurologi berkaitan dengan penuaan dan hipertensi. Oleh itu, kami 
menentukan status oksidatif dan keupayaan antioksidan mengikut perubahan umur 
pada korteks serebrum (CC), serebelum (CB) dan pangkal otak (BS) tikus hipertensi 
spontan (SHR) dan tikus Wistar-Kyoto (WKY). 
          Enam ekor tikus daripada strain WKY and SHR dikorbankan pada minggu 8, 
16, 24, 24, 32, 40, 48, 56 dan 64 setelah mengukur tekanan darah dan berat badan. 
CC, CB dan BS dikeluarkan dengan cara diseksi, dihomogenkan dan digunakan untuk 
penentuan berikut: bahan reaktif asid tiobarbiturik (TBARS), karbonil protein (PCO), 
superoksida dismutase (SOD), katalase (CAT), glutathion peroksidase (GPx), 
glutathion reduktase (GR), glutathion S-transferase (GST), glutathion terturun (GSH), 
glutathion teroksida (GSSG), status antioksidan keseluruhan (TAS) dan aktiviti enzim 
terikat pada membran (Na+,K+-ATPase, asetilkolinesterase – AChE). 
          SHR menunjukkan tekanan darah yang tinggi dan berat badan yang rendah 
pada semua titik masa kajian. Apabila dibandingkan dengan tikus kawalan (WKY), 
TBARS daripada minggu 24 dan PCO daripada minggu 32 ke atas meningkat secara 
signifikan pada semua bahagian otak SHR. Kandungan GSH dan nisbah GSH/GSSG 
adalah rendah bagi SHR daripada minggu 16 dan 24 ke atas, masing-masing pada 
semua bahagian otak. TAS dan aktiviti SOD dan GST menyusut secara signifikan 
pada semua bahagian otak daripada minggu 24 ke atas bagi SHR. Aktiviti GPx bagi 
SHR menunjukkan penyusutan signifikan pada CB dan BS daripada minggu 24 ke 
atas dan pada CC daripada minggu 56 ke atas. Aktiviti CAT bagi SHR adalah rendah 
secara signifikan pada CB daripada minggu 32 ke atas dan CC daripada minggu 56 ke 
 xxxvi
atas. Tidak terdapat perbezaan pada aktiviti CAT pada BS pada semua titik masa 
kajian. Aktiviti GR bagi SHR menunjukkan penyusutan signifikan pada CC, CB dan 
BS masing-masingnya daripada minggu 48, 16 dan 24 ke atas. Na+,K+-ATPase 
menunjukkan penyusutan signifikan dalam aktivitinya daripada minggu 32 ke atas 
pada semua bahagian otak SHR. Aktiviti AChE bagi SHR adalah rendah secara 
signifikan pada CC, CB dan BS masing-masingnya daripada minggu 24, 32 dan 48 ke 
atas. Semua tiga bahagian otak mempunyai persamaan dalam aktiviti SOD. 
Berbanding dengan CC, BS WKY dan SHR mempunyai TAS, aktiviti CAT dan GPx 
yang tinggi, dan aras TBARS dan PCO yang rendah. Terdapat persamaan dalam aras 
PCO dan aktiviti GPx pada CB dan BS, tetapi TAS dan aktiviti CAT yang tinggi dan 
aras TBARS yang rendah terdapat pada BS berbanding dengan CB. Walau 
bagaimanapun, kandungan GSH, nisbah GSH/GSSG dan aktiviti GST and GR adalah 
rendah secara signifikan pada BS berbanding dengan CC dan CB. CC dan CB 
mempunyai persamaan dalam aras TBARS dan PCO, kandungan GSH dan TAS, 
tetapi aktiviti GPx, CAT dan GR adalah rendah secara signifikan pada CC berbanding 
dengan CB.   
          Dengan ini dicadangkan bahawa kecenderungan bahagian otak terhadap stres 
oksidatif adalah dalam turutan: CC>CB>BS. Bersama dengan perkembangan 
hipertensi, terdapat peningkatan aras oksidan dan penyusutan keupayaan antioksidan 
berserta dengan perubahan dalam aktiviti enzim-enzim terikat pada membran pada 
CC, CB dan BS SHR. Oleh yang demikian, stres oksidatif mungkin memainkan 
peranan dalam penyakit neurologi berhubung dengan hipertensi.   
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CHAPTER 1 
INTRODUCTION 
 
1.1   Background of the study 
Cardiovascular disease is a major public health problem in Malaysia due to its high 
prevalence. This disease has emerged as the principal cause of mortality in our 
population and hypertension is considered as a prevalent risk factor (Lim et al., 2004). 
Hypertension is defined as systolic blood pressure (SBP) of 140 mmHg or greater 
and/or diastolic blood pressure (DBP) of 90 mmHg or greater or current treatment for 
hypertension with medication (Burt et al., 1995). A survey of 17,392 individuals aged 
30 and above during the National Health and Morbidity Survey 2 in 1996 showed a 
high prevalence of elevated blood pressure (Ministry of Health, Malaysia, 1996). The 
overall prevalence of hypertension among Malaysian adults was 29.9 %, with self-
reported hypertension 14.0 % and undiagnosed hypertension 15.9 %. It was found that 
41% of hypertensive patients had never been on medication and presented with life-
threatening complications (Ministry of Health, Malaysia, 1996). 
          Prolonged uncontrolled hypertension is known to cause brain damage from 
hypertensive encephalopathy (Ryan and Irawan, 2004; Koop, 2005), stroke (Reid, 
1994) and vascular dementia (Skoog et al., 1996). Hypertension is also a risk factor 
for myocardial infarction (Whelton, 1994), congestive heart failure (Fiebach et al., 
1989), end-stage renal disease (Kimura et al., 1996) and peripheral vascular disease 
(Stamler et al., 1993). The question of whether elevated blood pressure alone 
constitutes a risk factor for development of complications in the brain among 
hypertensive subjects is still unclear. Free radical has been proposed as an important 
predisposing pathogenic mechanism in the progression of hypertension and also the 
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development of its complications (Ohtsuki et al., 1995; Wen et al., 1996; Lerman et 
al., 2001). Several reports have documented that hypertension is associated with 
increased free radical production as well as reduction of antioxidant capacity 
(Nakazono, 1991; Tse et al., 1994; Jun et al., 1996; Koska et al., 1999). Therefore, it 
is possible that increased free radical production and reduction of antioxidant capacity 
in hypertension have a role in the pathogenesis of hypertensive brain damage. 
However, at what point in the development of hypertension, increased oxidative 
process and/or decrease in antioxidant capacity takes place in the brain is unknown. 
          Since free radicals are produced even in normal cellular metabolism in the 
brain, increased production of free radicals in pathophysiological conditions exceeds 
the capacity of the cell to provide protection against their damaging effect, leading to 
oxidative stress. Thus, the balance between free radicals generation and the 
antioxidant defense system is crucial in determining the extent of the damage caused 
by these highly reactive molecules. But, there is a lack of systematic biochemical data 
concerning free radicals production and antioxidant defenses in the development and 
progression of hypertension in the different brain regions. Therefore, this study was 
undertaken to obtain fundamental data on oxidative status and antioxidant capacity in 
a time-course manner in the cerebral cortex (CC), cerebellum (CB) and brain stem 
(BS) of spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats 
(WKY), from the age of 8 weeks to 64 weeks. It is also hoped that this study will 
serve as a basis for future study on human hypertension.  
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1.2   Free radicals   
  
A free radical can be defined as any molecular species capable of independent 
existence that possesses one or more unpaired electrons in its outer orbital 
(Gutteridge, 1995; Markesbery and Carney, 1999; Fang et al., 2002). They are 
generally unstable and very reactive. Once radicals are formed they can either react 
with another radical or with another non-radical molecule by various interactions. If 
two radicals meet, they can combine their unpaired electron, thus forming a covalent 
bond. A radical has potential to generate another radical leading to the chain reaction. 
          Free radicals and their metabolites, reactive oxygen species (ROS) are 
constantly formed in the body by several mechanisms, involving both endogenous and 
environmental factors (Young and Woodside, 2001). Major sources of free radicals in 
the body include mitochondrial leak, respiratory burst, enzyme reactions, 
autooxidation reactions, pollutants, UV light, ionizing radiation, xenobiotics etc. ROS 
is a collective term that includes all reactive forms of oxygen including both the 
radical and nonradical species that participate in the initiation and/or propagation of 
radical chain reactions (Cui et al., 2004). Examples of ROS which are free radicals 
include superoxide radical (O2.-), hydroxyl radical (.OH), peroxyl radical (RO2.), 
alkoxyl radical (RO.), hydroperoxyl radical (HO2.) and nitric oxide (NO.) (Fang et al., 
2002). Other ROS such as hydrogen peroxide (H2O2), peroxynitrite (ONOO-), 
hypochlorous acid (HOCl) and singlet oxygen (1O2) are not free radicals per se but 
have oxidizing effects that contribute to oxidative stress (Cai and Harrison, 2000; Cui 
et al., 2004).  
          ROS are formed in the reduction of molecular oxygen (O2) to water as follows 
(Equations 1 to 5) (Gutteridge, 1995): 
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Equation 1: 
O2  +  e  +  H+                    HO2.   (hydroperoxyl radical)      
    
Equation 2: 
HO2.                     H+  +  O2.-  (superoxide radical)      
 
Equation 3: 
O2.-  +  2H+  +  e                    H2O2   (hydrogen peroxide)       
 
Equation 4: 
H2O2  +  e                      OH-  +  .OH   (hydroxyl radical)          
 
Equation 5: 
.OH  +  e  +  H+                     H2O 
 
 
 
 
1.2.1   Superoxide radical (O2.-) 
O2.- is an an anionic radical formed by the reduction of O2 through the acceptance of a 
single electron (Cui et al., 2004). The hydroperoxyl radical (HO2.), the protonated 
form of O2.-, is both a more powerful oxidant and reductant than O2.-, but HO2. is 
unstable at physiological pH 7.4 and dissociates to O2.- (Gutteridge, 1995). O2.- has 
different properties depending on its solution environment. In aqueous solution O2.- is 
a weak oxidizing agent able to oxidize molecules such as ascorbic acid and thiols 
(Gutteridge, 1995). But O2.- is a much stronger reducing agent which can reduce 
several iron complexes such as cytochrome c and ferric-EDTA (Gutteridge, 1995). 
O2.- has limited reactivity with some proteins but is not reactive with lipids or DNA 
(Markesbery and Carney, 1999). O2.- is not membrane permeable and therefore its 
reaction is limited to the compartment in which it is generated (McIntyre et al., 1999). 
          O2.- is mainly formed in vivo by the electron transport chains in the 
mitochondria and microsomes through electron leakage, a phenomenon that increases 
with an increase in O2 utilization (Cui et al., 2004). O2.- is also formed by metal ion-
dependent oxidation of epinephrine and norepinephrine, and by the action of enzymes 
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such as tryptophane hydroxylase, indoleamine dioxygenase and xanthine oxygenase 
(Cui et al., 2004). Another source of O2.- is cyclooxygenase which is present in 
cerebral extracellular space (Kontos et al., 1985). It was found that O2.- can also be 
produced by brain nitric oxide synthase (NOS) from one-electron reduction of O2 
(Pou et al., 1992). In addition, O2.- can also be generated from O2 through 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidation by NADPH 
oxidase, oxidation of xanthine or hypoxanthine by xanthine oxidase and one-electron 
reduction of O2 by cytochrome P450 (Fang et al., 2002). 
          O2.- will not normally react with nitric oxide (NO.) to yield peroxynitrite 
(ONOO-) and peroxynitrous acid (HOONO) except when NO. is produced in large 
amount. O2.- is not a damaging ROS if compared to its derivatives such as .OH. It is 
considered biologically significant because it becomes the main source for the 
production of H2O2 and precursors for the generation of .OH. 
Equation 6: 
O2.-   +   O2.-  +  2H+                      H2O2   +  O2  
          O2.- disappears in aqueous solution rapidly through dismutation reaction in 
which hydrogen peroxide and oxygen are formed (Equation 6). The reaction is greatly 
accelerated by the superoxide dismutase (McCord and Fridovich, 1969).  
 
 
1.2.2   Hydrogen peroxide (H2O2) 
Any biological system producing O2.- will also produce H2O2 as a result of the 
dismutation reaction (Gutteridge, 1995). H2O2 is not a free radical because it contains 
no unpaired electron in the outer orbital. H2O2 is formed by addition of an electron 
and 2H+ to the O2.- under the influence of superoxide dismutase. Two O2
.- molecules 
can react with  H+ to form H2O2 and O2 (Equation 7).   
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Equation 7: 
2O2.-       +           2H+                                 H2O2     +     O2 
          This reaction is called dismutation reaction because radical reactant react 
together to form nonradical products (Fouad, 2003). In addition, several enzymes such 
as L-amino acid oxidase, glycolate oxidase, monoamine oxidase and nitric oxide 
synthase produces H2O2 directly by the transfer of two electrons to O2 (Halliwell, 
1992; Heinzel et al., 1992).  
          Unlike the charged O2.-, H2O2 crosses cell membrane freely (Halliwell and 
Gutteridge, 1985). This is because H2O2 readily mixes with H2O and is treated as a 
H2O molecule by the body and diffuses across cell membrane. Therefore H2O2 found 
in one location might diffuse to another location and cause damage to it. Damage 
occurs when H2O2 comes into contact reduced form of certain transition metals such 
as Fe2+ or Cu+. In the presence of transition metals, H2O2 is decomposed to yield the 
highly reactive hydroxyl radicals via the Haber-Weiss or Fenton reactions (Cui et al., 
2004). As H2O2 is lipid soluble, it can cause damage to localized Fe2+ containing 
membranes far from its site of origin (Marks et al., 1996). H2O2 is involved in the 
formation of HOCl and 1O2 in the presence of myeloperoxidase (MPO) from 
neutrophils during the destruction of foreign organisms in a response called 
respiratory burst (Tatsuzawa et al., 1999). 
 
 
1.2.3   Hydroxyl radical (.OH) 
The .OH is an extremely aggressive oxidant that can react at great speed with almost 
every biological molecule found in living cells including lipid, proteins, nucleic acids 
and carbohydrates (Halliwell and Gutteridge, 1985). Because of its low half-life 10-9 s 
at 37 0C, the direct action of .OH is confined to regions immediately in the vicinity of 
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its formation (Sies, 1993; Cui et al., 2004). .OH can be produced experimentally by 
various procedures including radiation or by decomposition of peroxynitrite (Cui et 
al., 2004). Although .OH formation can occur in various ways, the most important 
mechanism in vivo is likely to be the transition metal catalyzed decomposition of O2.- 
and H2O2 (Young and Woodside, 2001). H2O2 can react with transition metals such as 
iron II (Fe2+) or copper I (Cu+) in a reaction termed Fenton reaction as shown in 
equations 8 and 9 (Young and Woodside, 2001). 
Equation 8: 
Fe2+     +    H2O2                           Fe3+     +     .OH     +      OH-      
Equation 9:     
Cu+     +    H2O2                            Cu2+     +    .OH     +      OH-          
          .OH can also be produced when O2.- and H2O2 react together directly in the iron-
catalyzed reaction termed Haber-Weiss reaction (Equations 10 to 12) (Young and 
Woodside, 2001). But the rate constant for this reaction in aqueous solution is 
virtually zero.  
Equation 10: 
Fe3+       +       O2.-                             Fe2+    +      O2 
Equation 11: 
Fe2+       +       H2O2                          Fe3+    +     .OH     +     OH-     
 net result:           
Equation 12:             
O2.-        +      H2O2                         .OH     +     OH-     +      O2 
 
          The net result of the above reaction is known as the Haber-Weiss reaction. 
Under normal circumstances, most of the iron in the body are tightly bound to one of 
several proteins including transferrin, lactoferrin, haem proteins, ferritin or 
haemosiderin. However, in pathological conditions such as active inflammation and 
ischaemia reperfusion injury, excessive iron may be released from its sequestered 
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form leading to the generation of .OH by Fenton or Haber-Weiss reaction (Young and 
Woodside, 2001).  
 
 
1.2.4   Singlet oxygen (1O2) 
1O2 is not a free radical because it does not have an unpaired electron. It is considered 
as one of ROS due to its strong oxidizing capability in which the spin restriction of 
two unpaired electrons with parallel spins is removed (Gutteridge, 1995). It can 
induce various genotoxic, carcinogenic and mutagenic effects through its action on 
polyunsaturated fatty acids and nucleic acid (Cui et al., 2004). Formation of 1O2 is 
extremely important in photochemical reactions. 1O2 is produced in the presence of 
molecular oxygen in chlorophylls, retinal and flavins during pigment reaction (Fouad, 
2003). 1O2 can be formed in vivo by enzymatic activation of O2 through 
lipooxygenase activity during prostaglandin biosynthesis (Cadenas and Sies, 1984).  It 
can also be produced by physicochemical reactions such as thermal decomposition of 
endoperoxides and dioxetanes, reaction of ozone with human body fluids and reaction 
of H2O2 with HOCl (Cui et al., 2004). 
 
 
1.2.5   Nitride oxide (NO.) 
NO. is considered as a free radical with limited reactivity but it can react with O2, O2.-  
and transition metals to form more powerful oxidant (Markesbery and Carney, 1999). 
NO. is endogenously produced and initially characterized as endothelial-derived 
relaxing factor (Furchgott and Zawadzki, 1980). NO. is now found to be involved in 
biological actions ranging from vasodilation, neurotransmission, inhibition of platelet 
adherence and aggregation and macrophage and neutrophil-mediated killing of 
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pathogens (Moncada et al., 1991). It is synthesized from L-arginine in a variety of 
cells and tissues by nitric oxide synthase (NOS) (Marletta, 1993; Fang et al., 2002). 
Three isoforms of NOS account for NO. production including neuronal NOS (nNOS; 
type I) which originally identified as constitutive in neuronal tissue, inducible NOS 
(iNOS; type II) which is originally identified as being inducible by cytokines in 
activated macrophages and liver, and endothelial NOS (eNOS; type III) which is 
originally identified as constitutive in vascular endothelial cells (Fang et al., 2002). 
Production of NO. in the central nervous system by nNOS accounts for most of NO. 
activity (Yun et al., 1996). NO. is produced excessively in excitotoxicity, 
inflammation and ischaemia-reperfusion injury (Bredt and Snyder, 1994). High 
concentrations of NO. are toxic and interact with O2.- to form peroxynitrite (Beckman 
et al., 1990). 
 
 
1.2.6   Peroxynitrite (ONOO-) 
ONOO- is formed in vivo by the reaction of NO. with O2.- as shown in Equation 13 
(Althaus et al., 1994; Beckman and Koppenol, 1996).  
Equation 13: 
O2.-      +         NO.                                 ONOO- 
          Formation of ONOO- reduces the concentrations and biological effects of both 
O2.- and NO. in the body. But ONOO- is considered as a more potent oxidant as 
compared to O2.- and NO. because it has strong oxidizing activity with membrane 
lipids, carbohydrates, proteins and DNA (Pryor and Squadrito, 1995). At 
physiological pH, ONOO- is protonated to form peroxynitrous acid (HOONO), a 
relatively long-lived oxidant (Gutteridge, 1995). HOONO decomposes spontaneously 
to .OH and NO2 which are potent activators of lipid peroxidation (Beckman et al., 
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1990). ONOO- also serves as a nitrating agent promoting the addition of nitrogroups 
to aromatic and indolic groups in proteins containing tyrosine, phenylalanine and 
tryptophan thus inactivating proteins (Markesbery and Carney, 1999).  
 
 
 
1.2.7   Hypochlorous acid (HOCl) 
HOCl which is a powerful oxidant is formed in the body by the activated neutrophils 
during respiratory burst to kill organisms (Gutteridge, 1995). The heme-containing 
enzyme MPO present in the phagocyte cytoplasm can catalyze the formation of HOCl 
from H2O2 and chloride ions (Cl-) (Equation 14).  
Equation 14: 
H2O2     +      Cl-      +     H+                                     HOCl       +      H2O     
In addition, HOCl may also give rise to .OH by an iron-independent reaction 
(Equation 15) (Candeias et al., 1993) and iron-dependent reaction (Equation 16) 
(Candeias et al., 1994).  
Equation 15: 
HOCl      +      O2.-                                   .OH     +      Cl-      +      O2 
Equation 16: 
HOCl      +      Fe2+                                  .OH      +     Cl-      +      Fe3+ 
 
 
1.3   Cellular sources of free radicals 
Oxygen is required for the generation of all ROS, reactive nitrogen species (RNS) and 
other reactive species. The major reactions for the production of oxygen and nitrogen 
free radicals in the body are illustrated in Figure 1.1 (Fang et al., 2002). 
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Figure 1.1:  Production of oxygen and nitrogen free radicals and other reactive species 
in mammalian cells. AA, amino acid; Arg, L-arginine; BH4, (6R)-5,6,7,8,-tetrahydro-
L-biopterin; CH2O, formaldehyde; Cit, L-citrulline; DQ, diquat; ETS, electron 
transport system; FAD, flavin adenine dinucleotide (oxidized); FADH2, flavin 
adenine dinucleotide (reduced); Gly, glycine; H2O2, hydrogen peroxide; HOCl, 
hypochlorous acid; H.LOH, hydroxyl lipid radical; IR, inonizing radiation; L., lipid 
radical; LH, lipid (unsaturated fatty acid); LO., lipid alkoxyl radical; LOO., lipid 
peroxyl radical; LOOH, lipid hydroperoxide; MPO, myeloperoxidase; NAD+, 
nicotinamide adenine dinucleotide (oxidized); NADH, nicotinamide adenine 
dinucleotide (reduced); NADP+, nicotinamide adenine dinucleotide phosphate 
(oxidized); NADPH, nicotinamide adenine dinucleotide phosphate (reduced); .NO, 
nitric oxide; O2-, superoxide anion radical; .OH, hydroxyl radical; ONOO-, 
peroxynitrite; P-450, cytochrome P-450; PDG, phosphate-dependent glutaminase; 
Sar, Sarcosine; SOD, superoxide dismutase; Vit C, vitamin C; Vit E, vitamin E (α-
tocopherol) (Fang et al., 2002). 
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1.3.1   Autoxidation 
Autoxidation is a side reaction of the aerobic internal milieu. Biological molecules 
that can undergo autoxidation include catecholamines, haemoglobin, myoglobin, 
reduced cytochrome C, thiol, flavins, ferredoxin and cyclooxygenase (Del Maestro, 
1980; Kontos et al., 1985). Autoxidation of any of the above molecules in a reaction 
results in the reduction of the O2 and the formation of ROS. O2- is the primary radical 
formed (Del Maestro, 1980) (Figure 1.1-1).  
 
 
1.3.2   Respiratory burst 
Respiratory burst is an antimicrobial defense system. It aims to damage the 
membranes, DNA and other cellular components of invading organism. Activated 
macrophages, neutrophils, monocytes and eosinophils produce O2.- and H2O2 as one 
of the mechanisms to kill bacteria and fungi and to inactivate viruses (Halliwell, 
1997). It is also a potentially dangerous mechanism if it is activated inappropriately. 
This is exactly what happens in people with chronic inflammatory diseases such as 
inflammatory bowel disease or rheumatoid arthritis (Halliwell, 1997). Activation of 
cell membrane enzymes such as nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase by immunoglobulin-coated bacteria, immune complexes, 
complement 5a or leukotriene will initiate the respiratory burst with generation of O2.- 
(Fouad, 2003). HOCl generated by the action of MPO is bactericidal that attacks the 
membranes of bacteria and subsequently lysis of bacteria occurs (Figure 1.1-2). 
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1.3.3   Mitochondrial leak  
Free radicals are constantly formed in the cells by normal metabolic processes, as the 
reduction of O2 to H2O by the mitochondrial electron transport chain (Figure 1.1-3). 
The main sites of O2.- production are in the mitochondrial respiratory chain of 
enzymes which includes nicotinamide adenine dinucleotide dehydrogenase (complex 
I) and ubiquinone Q-cytochrome b complex (complex III) (Boveris and Chance, 1973; 
Chance et al., 1979; McIntyre et al., 1999).  Production of O2.- is regulated by the 
respiratory chain carriers which includes NAD-linked substrates, succinate, adenosine 
diphosphate (ADP) and O2 (Boveris and Chance, 1973). In the mitochondrial 
respiration, O2 itself is reduced in such way that two electrons and two pairs of 
protons are accepted by each oxygen atom leading to the formation of a H2O 
molecule. But mitochondrial electron transport system is not always perfect. There is 
a constant leak of a few electrons into the mitochondrial matrix, leading to univalent 
reduction of O2 that forms O2.- (Becker et al., 1999). Under physiologic conditions, 
about 1% to 3% of the O2 consumed by the body is converted into O2.- and other ROS 
as by-products (Tritschler et al., 1994; Sohal and Weindruch, 1996). Production of 
O2.- by the mitochondria increases when the respiratory chain is under reduced 
conditions or when mitochondria are damaged (Chance et al., 1979). As mitochondria 
are the major sites of O2.- production, paradoxically they also become the main target 
of free radical attacks. ROS generated by mitochondria can cause damage to 
mitochondrial components and initiate degradative processes (Cadenas and Davies, 
2000). Increased production of O2.- and H2O2 in the mitochondria is associated with 
aging (Ames et al., 1995). It has been found that O2.- overproduced in a mitochondrial 
compartment when uncoupled from antioxidant defenses induces impairment of 
mitochondrial function (Murakami et al., 1998).  
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1.3.4   Microsomes 
The microsomal cytochrome P450 enzymes are composed of two functional units 
embedded in the membrane of the endoplasmic reticulum:- (1) cytochrome P450 
which binds the substrate and oxygen and carries out the reaction, (2) cytochrome 
P450 reductase which transfers electrons from nicotinamide adenine dinucleotide 
phosphate (NADPH) (Marks et al., 1996) (Figure 1.1-4). There are about 100 
different P450 isoenzymes in the human with different but overlapping specificities 
(Marks et al., 1996). It was shown that isolated microsomes can generate O2.- and 
H2O2 with nicotinamide adenine dinucleotide (NADH) and NADPH supplement 
(Kathan and Ullrich, 1982). The microsomal cytochrome P450 enzymes are formed 
abundantly in the liver in which they involve in xenobiotic metabolism. It was shown 
that cytochrome P450 reductase can reduce inorganic compounds such as paraquat 
(Brigelius and Anwer, 1981) and diquat (Smith et al., 1985) to form an unstable 
organic radical. Then, the unstable radical donates its electron to O2 to form O2.-, 
which can undergo one-electron reduction to generate more potent reactive radicals. 
 
 
1.3.5   Peroxisomes 
Peroxisomes contain several enzymes which include D-amino acid oxidase and fatty 
acyl-CoA oxidase that generate H2O2 but not O2.-  (Chance et al., 1979) (Figure 1.1-
5). Liver is the primary organ which contributes significantly to the overall H2O2 
production. H2O2 can be generated in peroxisomes by degradation of long-chain fatty 
acids by fatty acyl-CoA oxidase (Conway et al., 1987). Prolonged starvation or 
fasting can induce H2O2 production through peroxisomal oxidation of fatty acids 
(Conway et al., 1987). 
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1.3.6   Cytosol 
Xanthine oxidoreductase is responsible for formation of ROS in the cytosol. It is 
involved in catalyzing the oxidation of hypoxanthine and xanthine in the process of 
purine metabolism (Cai and Harrison, 2000). Xanthine oxidoreductase can exist in 
two interconvertible forms either as xanthine dehydrogenase or xanthine oxidase. The 
former reduces NAD+ whereas the latter prefers O2, leading to the production of both 
O2.- and H2O2. Both enzymes can be found abundantly in sinusoidal endothelial cells, 
hepatocytes and Kupffer cells (Wiezorek et al., 1994). In pathological conditions such 
as ischaemia reperfusion, production of xanthine and xanthine oxidase are greatly 
enhanced, thus providing xanthine oxidase with the reducing equivalents it needs to 
convert O2 to O2.- and H2O2 (Xia and Zweier, 1995). This is because, during 
reoxygenation, ATP is converted to ADP, AMP and adenosine, which can be 
degraded further to inosine, hypoxanthine and xanthine. Xanthine oxidase catalyzes 
the reaction of hypoxanthine to xanthine and subsequently oxidizes xanthine to 
produce uric acid, O2.- and H2O2 (Parks and Granger, 1986) (Figure 1.1-6). 
 
 
 
1.4   Oxidative stress and cellular damage 
Free radicals have been previously shown to be capable of causing cellular damage to 
biomolecules such as lipids, proteins and nucleic acids (Sohal et al., 1995; Cai et al., 
1996; Liu et al., 1996; Cai and Harrison, 2000). Oxidative stress is a condition when 
the level of free radicals exceeds the endogenous antioxidant defense mechanisms of 
the host which can be due to an increased production of free radicals and/or a 
decrease of antioxidant defenses (Markesbery and Carney, 1999; Sanchez-Alvarez et 
al., 2002). When the increased demand on the cell’s capacity to detoxify free radicals 
is not met, free radicals oxidize biomolecules, leading to accumulation of toxic 
 16
oxidation products such as aldehydes or isoprostanes from lipid peroxidation, protein 
carbonyls from protein oxidation and oxidized base adducts from DNA oxidation. 
These oxidized products can be used as markers for excess oxidative status. 
 
 
 
1.4.1   Lipid peroxidation           
Lipids are probably the most susceptible biomolecules to free radical attack. Cell 
membranes are the major site of lipid peroxidation because they are rich in 
polyunsaturated fatty acids (PUFA). The presence of a double bond in the PUFA side 
chains of membrane lipids weakens the C-H bonds on the carbon atom adjacent to the 
double bond which allows easy removal of H+. Lipid peroxidation causes gradual loss 
of membrane fluidity and membrane potential. Membrane permeability to ions such 
as Ca2+ is increased and if continued long enough can lead to loss of membrane 
integrity (Halliwell and Gutteridge, 1985). Membrane-bound enzymes and receptors 
are also inactivated. A study has shown that modifications of lipid composition may 
alter Na+,K+-ATPase activity (Sanderman, 1978). Degradation of fatty acids leads to 
formation of aldehydes including malondialdehyde (MDA) and 4-hydroxynonenal (4-
HNE) which are cytotoxic to cells (Esterbauer et al., 1991). MDA is produced during 
peroxidation of fatty acids of both the n-6 series such as, linoleic and arachidonic 
acids and the n-3 series such as, docosahexaenoic acid (Pryor and Stanley, 1975).             
          The oxidation of lipids by free radicals generally consists of three steps: 
initiation, propagation and termination (Halliwell and Gutteridge, 1985; Gutteridge, 
1995). (1) Initiation, in which a free radical compound such as hydroxyl radical 
extracts a hydrogen atom from a polyunsaturated lipid (LH), resulting in the 
formation of a lipid radical (L.) (Equation 17). (2) Propagation, in which the lipid 
radical undergoes molecular rearrangement to form a conjugated diene which then 
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reacts with O2 to give rise to a lipid peroxy radical (LOO.) (Equation 18). Lipid 
peroxyl radical, in turn, starts a self-perpetuating chain reaction, abstracts a hydrogen 
atom from another fatty acid to form lipid hydroperoxide (LOOH) and lipid radical 
(L.) (Equation 19). LOOH formed during the chain reaction are a complex mixture of 
isomers. They are stable molecules at physiological temperature but their 
decomposition is catalyzed by transition metals. (3) Termination, in which the 
radicals themselves, or between the radicals and antioxidants, giving rise to 
nonradical products or unreactive radicals. For example, two peroxyl radicals 
annihilate each other to terminate the chain by forming of cyclic peroxide (LOOL) 
(Equation 20). One peroxyl radical and one lipid radical annihilate each other to form 
cyclic peroxide (Equation 21). This chain reaction can also be terminated by 
antioxidants such as vitamin E (α-tocopherol) by donating hydrogen atom to peroxyl 
radical, stopping it from initiating (Equation 22). This leaves behind an unpaired 
electron on the vitamin E. But vitamin E radical is unreactive and degrades 
harmlessly. Vitamin E radical can also be reduced back to vitamin E by ascorbic acid 
(vitamin C) which is also an antioxidant (Slater, 1984).  The peroxyl radicals formed 
in lipid peroxidation survive long enough to be able to move to new fatty acid 
molecules. So they can readily be scavenged by various antioxidants. 
Initiation 
Equation 17: 
LH      +       .OH                            L.      +        H2O 
 
Propagation 
Equation 18: 
L.        +         O2                            LOO. 
 
Equation 19: 
LOO.    +      LH                             LOOH      +       L.         
 
Termination 
Equation 20: 
LOO.    +   LOO.                            LOOL      +      O2 
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Equation 21: 
LOO.    +      L.                               LOOL     
                                     or 
Equation 22: 
LOO.   +   Vit E                              LOOH      +     Vit E.  
 
          Lipid peroxidation has been quantitatively assessed by measuring (1) MDA 
levels by the thiobarbituric acid reactive substances (TBARS) assay, (2)  alterations in 
PUFA and (3)  the breakdown products of PUFA, such as aldehydes and isoprostanes 
(Markesbery and Carney, 1999). Normally, TBARS test is used as an indicator of the 
major lipid peroxidation burden because it is easy to perform and inexpensive (Moore 
and Roberts, 1998) even though they also measure a variety of products including 
non-lipid derived MDA, C3 to C10 aldehydes and species resulting from chemical 
interaction among non-lipid molecules during the assay (Markesbery and Carney, 
1999). No single method is adequate for all stages of lipid peroxidation in a biological 
system (Gutteridge, 1995).   
 
 
1.4.2   Protein oxidation 
Proteins are less vulnerable than PUFA to free radical attack. Following exposure to 
free radicals, proteins can undergo certain types of modifications including the 
oxidation of the amino acid residues and/or peptide backbone of proteins resulting in 
the generation of protein carbonyl (PCO) (Marnett et al., 2003). The process is 
initiated by hydrogen abstraction from the α-carbon in a peptide chain. If two proteins 
radicals are in close proximity, they may cross-link with one another by radical 
coupling. Alternatively, molecular oxygen can attack the α-carbon-centred radical to 
form peroxide intermediates leading to rearrangement and subsequent cleavage of the 
peptide bond to form carbonyl-containing peptides (Dean et al., 1997). Carbonyl 
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formation is an important detectable marker of protein oxidation that can be measured 
by reaction of 2,4-dinitrophenylhydrazine with proteins to form the corresponding 
hydrazones (Evans et al., 1999; Marnett et al., 2003). 
          In proteins, the amino acids such as cysteine, tyrosine and methionine are 
particularly vulnerable to modifications by O2.-, .OH, HOCl, peroxynitrous acid 
(ONOOH) and nitrosoperoxycarbonate (ONO2CO2-) (Marnett et al., 2003). 
Reversible oxidation of the sulfhydryl group on cysteine converts it to cysteine 
sulfenic acid, which can react with thiols or undergo further irreversible oxidation to a 
sulfinic acid and a sulfonic acid (Claiborne et al., 1999). A variety of oxidative 
modifications can occur to tyrosine side chains in proteins, including formation of 
0,0’-dityrosine, 3,4-dihydroxyphenylalanine, 3-nitrotyrosine and 3-chlorotyrosine 
(Marnett et al., 2003). Oxidation of methione residues in proteins results in the 
formation of methione sulfoxide (Levine et al., 2000). Free radicals modify proteins 
that play important roles in biological functions. Protein oxidation would be expected 
to affect a variety of cellular functions involving proteins including protein synthesis, 
energy production, signal transduction and transport systems (Evans et al., 1999; 
Stadtman and Levine, 2000; Sohal, 2002; Marnett et al., 2003). Protein oxidation may 
have secondary effect to other biomolecules such as development of new antigens 
provoking autoimmune responses (Evans et al., 1999). Carbonyl groups may also be 
introduced into proteins by glycation and reaction with glycoxidation and lipid 
peroxidation products (Butterfield and Stadtman, 1997). Lipid peroxidation products 
such as MDA and 4-HNE have been shown to react with cysteine, histidine and lysine 
residues in proteins (Uchida, 2000). Some common protein targets for free radicals 
attack are shown in Table 1.1. 
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Table 1.1:  Some common protein targets for free radicals attack  
(Marnett et al., 2003) 
 
 
 
 
 
Protein targets Residue modified Modifying 
agents 
Biological 
consequences 
 
Enzymes 
Caspases 
 
 
Protein tyrosine 
Phosphatases 
 
 
 
Tyrosine 
hydroxylase 
 
Mn-SOD 
 
  
Structural and 
membrane proteins 
Tubulin 
 
 
N-methyl-D-
aspartate receptor 
channel 
 
Transcription factors 
AP-1 
 
 
 
OXyR 
 
Catalytic cysteine 
 
 
Catalytic 
cysteine, 
active-site 
tyrosine 
 
Active-site 
tyrosine 
 
Active-side 
tyrosine 
 
 
 
cysteine residue 
 
 
Extracellular 
cysteine residue 
 
 
 
Cysteine in DNA-
binding domain 
 
 
Cysteine residues 
 
HO., nitrosating 
agents 
 
HO.,  O2.-, 
nitrosating 
agents, 
ONOOH 
 
ONOOH 
 
 
ONOOH 
 
 
 
 
4-HNE, 
ONOOH 
 
Nitrosating 
agents 
 
 
 
Various 
oxidants, NO 
 
 
HO., nitrosating 
agents 
 
Glutathionylation, 
inactivation 
 
Glutathionylation, 
inactivation, 
accumulation of 
phosphotyrosine 
 
Inhibition of 
dopamine synthesis 
 
Prevention of  O2.- 
detoxification 
 
 
 
Disruption of 
microtubule 
networks 
 
Inactivation, 
reduced Ca2+ influx 
 
 
Glutathionylation, 
inhibition of DNA 
binding 
 
Glutathionylation, 
transcriptional 
activation of OxyR-
responsive genes 
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1.4.3   DNA oxidation 
Free radicals can also attack DNA molecule and cause DNA damage. Oxidative 
alterations of DNA molecules include strand breaks, sister chromatid exchange, 
DNA-DNA and DNA-protein crosslinking and base modifications (Cochrane, 1991; 
Davies, 1995). DNA can be damaged by hydroxyl radical, nitric oxide, halogen and 
lipid peroxidation products such as MDA and 4-HNE (Marnett et al., 2003).  
          Hydroxyl radical is particularly damaging because it is capable of modifying 
purine and pyrimidine bases of DNA as well as sugar backbones of DNA. Hydroxyl 
radical can add to double bonds of DNA bases or abstract hydrogen atoms from either 
methyl groups or deoxyribose residues (Chatgilialoglu and O’Neill, 2001). Hydroxyl 
radical can also add to the 7,8 double bond of purines to produce the 8-oxo-7,8-
dihydrodeoxyguanosine (8-oxo-dG). Hydroxyl radical reacts with pyrimidines by 
adding to the 5,6 double bond to generate a carbon-centred radical that reacts with 
molecular oxygen to form a hydroperoxide which is then reduced to 5-
hydroxymethyldeoxyuridine (5-hydroxymethyl-dU) (Marnett et al., 2003). 8-oxo-dG 
has been shown capable of inducing transversions of guanine (G) to thymine (T) or 
cytosine (C) in both in vitro replication experiments and in vivo mutagenesis 
experiments (Tan et al., 1999; Gentil et al., 2000). 8-oxo-7,8-dihydrodeoxyadenosine 
(8-oxo-dA) has been shown to induce adenine (A)→C mutations in in vitro 
replication experiments (Shibutani et al., 1993). Hydroxyl radical damage to 
pyrimidines produces 5-Hydroxydeoxycytidine (5-hydroxy-dC) which can induce 
C→T and C→A mutations in vitro and C→T transitions in vivo (Feig et al., 1994). 
The nonspecific binding of Fe2+ to DNA stimulates localized production of the 
hydroxyl radical which can cause strand breaks and base alterations in the DNA 
(Marks et al., 1996).    Free radical attack on DNA has been studied by analyses of all 
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these modified bases. One of the most studied oxidatively modified nucleoside is 8-
hydroxy-2’-deoxyguanosine (8-OHdG), which derives from hydroxyl attack on 
deoxyguanosine (Shigenaga and Ames, 1991). Some mutagenic consequences of 
replication of endogenous DNA adducts are shown in Table 1.2.  
 
Table 1.2: Mutagenic consequences of replication of endogenous DNA adducts 
(Marnett et al., 2003) 
 
 
   Damage type Mutations 
Adenine 
8-Oxo-dA 
Etheno-dA 
 
Cytosine 
5-Methyl-dC 
Etheno-dC 
 
Guanine 
O6-methy-dG 
M1dG 
8-Bromo-dG 
8-Oxo-dG 
1,N2-etheno-dG 
 
Thymine 
Thymine glycol 
 
 
A→C 
A→G 
 
 
C→T 
C→A, C→T 
 
 
G→T 
G→T, G→A 
G→T 
G→A 
G→A, G→T 
 
 
T→C 
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1.5   Free radicals and membrane-bound enzymes  
The cellular membrane of the brain is abundant with enzymes like sodium-potassium 
adenosine triphosphatase (Na+,K+-ATPase) and acetylcholinesterase (AChE). Since 
brain membrane is rich in PUFA, the oxidation of membrane lipids may lead to 
inactivation of these membrane-bound enzymes. 
 
 
1.5.1   Na+,K+-ATPase 
Na+,K+-ATPase (EC 3.6.1.3) is a membrane-bound enzyme composed of two 
subunits: an α-catalytic subunit with a relative molecular weight of 90-110 kDa and a 
β-subunit with a molecular mass of 40-60 kDa (Kourie, 1998). It is a crucial enzyme 
responsible for maintaining the ionic gradient necessary for neural excitability. It is 
present at high concentrations in the brain cellular membrane, consuming about 40-
50% of the ATP generated in this tissue (Erecinska and Silver, 1994). Na+,K+-ATPase 
utilizes the energy derived from ATP hydrolysis to pump out Na+ from inside the cell 
and to transfer K+ from outside to cytosol against their concentration gradients, 
generating internal negative charges (Chakraborty et al., 2003). This membrane-
bound enzyme requires phospholipids for its activity and is highly vulnerable to 
oxidative stress and the mechanism of inactivation under this condition involves 
disruption of phospholipid microenvironment of the enzyme or direct damage to 
enzyme protein by reactive oxygen radicals or lipid peroxidation products (Jamme et 
al., 1995; Fleuranceau-Morel et al., 1999; Lehtosky et al., 1999). The inactivation of 
Na+,K+-ATPase leads to partial membrane depolarization, allowing excessive Ca2+ 
entry inside the neurons resulting in toxic events like excitotoxicity (Chakraborty et 
al., 2003). It was found that Na+,K+-ATPase activity is decreased in cerebral 
ischaemia (de Souza Wyse et al., 2000) and in various neurodegenerative disorders 
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such as Alzheimer’s disease (Lees, 1993; Hattori et al., 1998). The inhibitory effects 
of iron-generated free radicals on the activity of Na+,K+-ATPase of red blood cells 
can be reversed by antioxidants (Rohn et al., 1993). 
 
 
1.5.2   AChE 
AChE (EC 3.1.1.7) is a type B carboxylesterase that rapidly hydrolyzes the 
neurotransmitter acetylcholine (ACh) at brain cholinergic synapses as well as at 
neuromuscular junctions (Taylor and Radic, 1994). Neurotransmission mediated by 
ACh contributes to numerous physiological functions (Borovicka et al., 1997) as well 
as to memory, learning and panic response (Everitt and Robbins, 1997; Battaglia, 
2002). There are three AChE isoforms: synaptic (AChE-S), readthrough (AChE-R) 
and erythrocytic (AChE-E) (Grisaru et al., 1999). AChE-S constitutes the principal 
multimeric enzyme in brain and muscle; AChE-R appears in embryonic and tumor 
cells and is induced under psychological, chemical and physical stress; and ACh-E 
associates with red blood cell membrane. It has been shown that various forms of 
AChE have experimentally identical catalytic properties (Schwarz et al., 1995). The 
classical role of AChE is to terminate cholinergic neurotransmission by hydrolysis of 
ACh. However, it was found that AChE is co-released from the dopaminergic 
neurons, implying an interaction between AChE and dopamine which is important for 
the dopaminergic function (Klegeris et al., 1995). There is evidence that abnormality 
in central cholinergic system of SHR may contribute to the development and/or 
maintenance of hypertension (Buccafusco and Spector, 1980; Makari et al., 1989). 
For example, intravenous injection of AChE inhibitor evoked an enhanced 
hypertensive response in SHR as compared with WKY (Buccafusco and Spector, 
1980; Makari et al., 1989). Intracerebroventricular injection of cholinergic blocker 
